(Q64886992)
Statements
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study (English)
de Oliveira CF
Lacave AJ
Wolff JP
di Re F
Namer M
Maskens A
George M
Dalesio O
1 January 1990